An evaluation of the model for end-stage liver disease and serum C-reactive protein as prognostic markers in intestinal failure patients on parenteral nutrition

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 1, 2009, Pages 55-61

  Putchakayala, Krishna ^a   Polensky, Sharon ^b   Fitzhugh, Judith ^b   Cohran, Valeria ^a   Buchman, Alan ^a   Fryer, Jonathan ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

C reactive protein; Intestinal failure; Model for end stage liver disease; Parenteral nutrition associated liver disease

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENTEROPATHY; FEMALE; HOSPITAL; HUMAN; LIVER DISEASE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONALCOHOLIC FATTY LIVER; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SHORT BOWEL SYNDROME; TIME OF DEATH;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DISEASE PROGRESSION; HUMANS; INTESTINAL DISEASES; KAPLAN-MEIERS ESTIMATE; LIVER FAILURE; MODELS, BIOLOGICAL; PARENTERAL NUTRITION; PROGNOSIS; RETROSPECTIVE STUDIES; SEPSIS; SHORT BOWEL SYNDROME;

EID: 60149112231     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607108322395     Document Type: Article

References (31)

1. O'Keefe S., Buchman A., Fishbein T., Jeejeebhoy K., Jeppesen P., Shaffer J. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006 ; 4: 6-10.
2. Carbonnel F. The role of anatomic factors in nutritional autonomy after extensive bowel resection. JPEN J Parenter Enteral Nutr. 1996 ; 20: 275-280.
3. Stringer MD Short bowel syndrome. Arch Dis Childhood. 1995 ; 73: 170-173.
4. Freund HR Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition. 1999 ; 134: 11-14.
5. Buchman AL Total parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2002 ; 26 (Suppl): S43 - S48.
6. Quigley EM Hepatobiliary complications of total parenteral nutrition. Gastroenterology. 1993 ; 104: 286-301.
7. Kelly DA Liver complications of pediatric parenteral nutritionepidemiology. Nutrition. 1998 ; 14: 153-157.
8. Angelico M., Guardia PD Hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther. 2000 ; 14: 54-57.
9. Stanko RT Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition. Gastroenterology. 1987 ; 92: 197-202.
10. Ito Y. Liver dysfunction associated with long-term total parenteral nutrition in patients with massive bowel resection. JPEN J Parenter Enteral Nutr. 1991 ; 15: 271-276.
11. Craig RM Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology. 1980 ; 79: 131-137.
12. Bowyer BA Does long-term home parenteral nutrition in adult patients cause chronic liver disease ? JPEN J Parenter Enteral Nutr. 1985 ; 9: 11-17.
13. Chan S. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery. 1999 ; 126: 28-34.
14. Wiesner R., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003 ; 124: 91-96.
15. Buchman AL, Scolapio J., Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003 ; 124: 1111-1134.
16. Ford ES, Giles WH, Myers GL, Rifai N., Ridker PM, Mannino DM C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin Chem. 2003 ; 49: 1353-1357.
17. Yasojima K., Schwab C., McGeer EG, McGeer PL Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res. 2000 ; 887: 80-89.
18. Jabs W., Theissing E., Nitschke M., et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation. 2003 ; 108: 1428-1431.
19. Vermeire S., Van Assche G., Rutgeerts P. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nature Clin Practice Gastroenterol Hepatol. 2005 ; 2: 580-586.
20. Shiota G., Umeki K., Okano J., Kawasaki H. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases. J Med. 1995 ; 26: 295-308.
21. Shima M. Comparative study of C-reactive protein in chronic hepatitis B and chronic hepatitis C. Tohoku J Exp Med. 1996 ; 178: 287-297.
22. Park SH Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol. 2004 ; 19: 694-698.
23. Koruk M. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis. Turk J Gastroenterol. 2003 ; 14: 12-17.
24. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant. 2005 ; 5: 307-313.
25. Black S. C-reactive protein. J Biol Chem. 2004 ; 279: 48487-48490.
26. Matsui J. Nutritional, hepatic and metabolic effects of cachectin/tumor necrosis factor in rats receiving TPN. Gastroenterology. 1993 ; 104: 235-243.
27. Keith M. Nutrition support affects the distribution and organ uptake of cachectin/tumor necrosis factor in rats. JPEN J Parenter Enteral Nutr. 1995 ; 19: 341-350.
28. Keith M. Nutrition support affects the levels of circulating soluble TNF receptors in ICU patients. 24th Clinical Congress, American Society for Parenteral and Enteral Nutrition. 2000 :S20.
29. Ling PR Inflammatory mediators in patients receiving long-term home parenteral nutrition. Digest Dis Sci. 2001 ; 46: 2484-2489.
30. Hise ME Inflammatory mediators and immune function are altered in home parenteral nutrition patients. Nutrition. 2006 ; 22: 97-103.
31. Vermeire S., Van Assche G., Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflam Bowel Dis. 2004 ; 10: 661-665.